Key facts
- This page summarizes Todd Pendleton's Form 4 filing for Dolby Laboratories, Inc. (DLB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Feb 2025, 17:17.
Todd Pendleton - 19 Feb 2025 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)
- Reporting relationship
- SVP, Chief Marketing Officer
- Issuer ticker
- DLB
- Reported as of
- 19 Feb 2025
- Net transaction value
- -$999,852
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2025, 17:17:52 UTC
- Prior SEC filing
- 18 Dec 2024
- Next SEC filing
- 17 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Rodriguez as Attorney-in-Fact for Todd Pendleton
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Todd Pendleton filed Form 4 for Dolby Laboratories, Inc. (DLB) on 21 Feb 2025.
Change
- Previous filing in this sequence was filed on 18 Dec 2024.
- Current net transaction value: -$999,852.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DLB
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $517,816
- Shares
- +7,286
- Change %
- +15%
- Price
- $71.07
- Shares after
- 55,411
- Date
- 19 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
DLB
transaction
Class A Common Stock
Sale
- Transaction value
- $1,517,668
- Shares
- -18,121
- Change %
- -33%
- Price
- $83.75
- Shares after
- 37,290
- Date
- 19 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DLB
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -7,286
- Change %
- -35%
- Price
- $0.000000
- Shares after
- 13,358
- Date
- 19 Feb 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 7,286
- Exercise price
- $71.07
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares held following the reported transactions include 37,290 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Footnote F2
This option was granted for a total of 29,143 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter.
Footnote F3
The shares were sold in multiple transactions at prices ranging from $83.41 to $84.19, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.